Depression: 6 Expert Takes Beyond Serotonin

Depression is the number four cause of disability worldwide and, by Andrew Huberman's account, affects roughly 5% of people. Yet the story most of us were told about it, that it is simply low serotonin, is now being openly challenged on the biggest podcasts. Huberman, Joe Rogan and Tim Ferriss have each hosted researchers and clinicians who lay out a messier and more hopeful picture. Here are six of their most concrete claims, each with the clip so you can hear it in full.

This is not medical advice, and depression is serious. Everything below is something a named expert said on a specific episode, not guidance from us. If you are struggling, especially with thoughts of self-harm, please reach out to a doctor or a crisis line rather than a blog post.

The loudest theme across these shows is doubt about the serotonin chemical imbalance story. On Huberman's podcast, Dr. Nolan Williams argues the theory has to be wrong, pointing out that transcranial magnetic stimulation relieves depression without adding any serotonin at all. If correcting serotonin were the mechanism, a treatment that ignores serotonin should not work.

The critique gets sharper on Joe Rogan's show. Brigham Buhler, a former Eli Lilly sales rep, calls the serotonin imbalance theory hogwash and claims that in trials SSRIs beat placebo by only about two points on a 52-point depression scale. Rogan himself asserts the theory is not real and that the system is financially incentivized to keep patients medicated. These are contested claims, but they are coming from inside the industry, which is part of why they land.

Huberman's own framing moves the cause upstream. In his Huberman Lab Essentials on depression he describes much of major depression as driven by excessive, unchecked inflammation rather than a simple neurotransmitter shortage, a shift that reframes it as a whole-body condition. That fits a striking data point he cites: the American Heart Association added depression as the fourth major risk factor for coronary artery disease.

Genes matter too. Huberman notes that if one identical twin has major depression, the other has roughly a 50% chance of it, with risk rising the closer the family relation. And the condition leaves a physical signature: he calls early-morning waking, typically 3 to 5 AM with an inability to fall back asleep, a hallmark vegetative symptom that separates clinical depression from an ordinary low mood.

If there is one intervention the experts return to, it is movement. On Rogan's show, Brigham Buhler claims that in head-to-head studies exercise outperforms antidepressants by roughly five times, and red-light therapy by about twice, versus placebo. Whatever the exact multiplier, the direction is consistent across the episodes.

Huberman offers a reason why. He explains that aerobic and resistance exercise shuttle a compound called kynurenine into muscle, where it is used up, protecting the brain from a pathway that otherwise pushes toward depression. Exercise, in that telling, is not just a mood boost but a way of clearing a specific chemical route to the disease.

Several guests point away from the pill bottle entirely. Huberman, drawing on work with Dr. Samer Hattar, explains that light input for mood uses a different brain region than the circadian clock, one that projects to the prefrontal cortex implicated in depression, which is part of why winter light and low mood track together. The brain, he notes elsewhere, averages light exposure across days precisely enough to register the changing seasons.

The gut is the other frontier. On Rogan's episode with Michael Pollan, the point is made that most of the body's serotonin is produced in the gut, not the brain, and that gut microbes strongly influence mood. Huberman adds nuance: that gut serotonin stays in the gut, but its levels are relayed by the vagus nerve to raise serotonin and mood in the brain. On the diet side, he notes creatine can augment the SSRI response, citing a 2012 American Journal of Psychiatry trial in women, and that the ketogenic diet has decent evidence for treatment-refractory depression by raising GABA activity.

For depression that does not respond to anything else, the experts get excited about stimulation. On Tim Ferriss's podcast, the Stanford-developed SAINT protocol, an accelerated form of TMS, is described as producing 70 to 80% remission in many patients, an effect that can be sustained with periodic booster sessions. That is a remarkable number for treatment-resistant cases.

The vagus nerve is the other target, though the experts urge caution. Ferriss warns that there are only two ways to stimulate it directly, an implanted electrode or focused ultrasound, and that the clip-on ear and neck TENS units marketed as vagus nerve stimulators are non-specific and should not be called that. On Huberman's show, Dr. Karl Deisseroth admits vagus stimulation is used against depression largely because the nerve is easy to reach, not because anyone fully understands the mechanism.

The area everyone is watching is psychedelic therapy. On Huberman's podcast, psychopharmacologist Dr. Matthew Johnson says that just one to three high-dose sessions can produce improvements in depression months later, and improvements in addiction more than a year out, a durability no daily pill offers.

The approach is unlike anything in conventional psychiatry. Johnson describes plans to study psilocybin in retired MMA fighters with histories of repetitive head impact, hoping to measure both depression relief and actual brain repair at once. It is early, it is not a home remedy, and every one of these studies is run under close medical supervision.

Is depression really caused by a chemical imbalance?

Several experts on these shows say no. Dr. Nolan Williams argues the serotonin theory must be wrong because TMS relieves depression without touching serotonin, and former pharma rep Brigham Buhler calls the imbalance idea hogwash. Huberman instead frames much of major depression as driven by inflammation.

What is a hallmark symptom of clinical depression?

Huberman points to early-morning waking, often between 3 and 5 AM with an inability to fall back asleep, as a hallmark vegetative symptom that helps distinguish major depression from an ordinary low mood.

Do antidepressants actually work?

It is contested. Brigham Buhler claims on Rogan's show that SSRIs beat placebo by only about two points on a 52-point scale. Huberman explains that drugs like Prozac, Zoloft and Wellbutrin raise the baseline level of serotonin and dopamine rather than the sharp peaks, a different effect than many people expect.

What helps depression besides medication?

Across these episodes the recurring answers are exercise, which Huberman says clears a pro-depression chemical pathway, morning light, and for severe cases brain stimulation like the SAINT TMS protocol that Tim Ferriss discusses. Supervised psychedelic therapy is the emerging area Huberman's guests are most excited about.

Put together, the message from Huberman, Rogan, Ferriss and their guests is not that antidepressants are worthless, but that the simple low-serotonin story is being replaced by something richer: inflammation, genetics, light, the gut, exercise, brain stimulation and, increasingly, supervised psychedelics. None of it is a substitute for professional care. Use the clips to understand the debate, then take questions about your own mind to a clinician.